Literature DB >> 3258029

PET-FDG of untreated and treated cerebral gliomas.

G Di Chiro, R A Brooks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3258029

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  9 in total

Review 1.  Positron emission tomography (PET): expanding the horizons of oncology drug development.

Authors:  Lisa A Hammond; Louis Denis; Umber Salman; Paul Jerabek; Charles R Thomas; John G Kuhn
Journal:  Invest New Drugs       Date:  2003-08       Impact factor: 3.850

2.  Planar and SPECT imaging in the era of PET and PET-CT: can it survive the test of time?

Authors:  Abass Alavi; Sandip Basu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08       Impact factor: 9.236

3.  [11C]-Methionine PET: dysembryoplastic neuroepithelial tumours compared with other epileptogenic brain neoplasms.

Authors:  D S Rosenberg; G Demarquay; A Jouvet; D Le Bars; N Streichenberger; M Sindou; N Kopp; F Mauguière; P Ryvlin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

4.  The accumulation of 11C-methionine in cerebral glioma patients studied with PET.

Authors:  M Kameyama; R Shirane; J Itoh; K Sato; R Katakura; T Yoshimoto; J Hatazawa; M Itoh; T Ido
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

Review 5.  PET-CT in Clinical Adult Oncology-V. Head and Neck and Neuro Oncology.

Authors:  Richard H Wiggins; John M Hoffman; Gabriel C Fine; Matthew F Covington; Ahmed Ebada Salem; Bhasker R Koppula; Kathryn A Morton
Journal:  Cancers (Basel)       Date:  2022-05-31       Impact factor: 6.575

Review 6.  Tracer imaging in lung cancer.

Authors:  H M Abdel-Dayem; A Scott; H Macapinlac; S Larson
Journal:  Eur J Nucl Med       Date:  1994-01

Review 7.  From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.

Authors:  Richard L Wahl; Heather Jacene; Yvette Kasamon; Martin A Lodge
Journal:  J Nucl Med       Date:  2009-05       Impact factor: 10.057

8.  Clinical application of 18F-FUdR in glioma patients--PET study of nucleic acid metabolism.

Authors:  M Kameyama; K Ishiwata; Y Tsurumi; J Itoh; K Sato; R Katakura; T Yoshimoto; J Hatazawa; M Ito; T Ido
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

9.  Clinical value of fluorine-18α-methyltyrosine PET in patients with gliomas: comparison with fluorine-18 fluorodeoxyglucose PET.

Authors:  Keishi Horiguchi; Masahiko Tosaka; Tetsuya Higuchi; Yukiko Arisaka; Kenichi Sugawara; Junko Hirato; Hideaki Yokoo; Yoshito Tsushima; Yuhei Yoshimoto
Journal:  EJNMMI Res       Date:  2017-05-31       Impact factor: 3.138
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.